|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Maryland Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MarylandLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
GenVec, Inc.
| GenVec, Inc. 65 West Watkins Mill Road Yard Gaithersburg, MD 20878 | |
| | Phone: | (617) 242-9100 | Fax: | (617) 242-0070 | Year Established: | 1989 | Employees: | 70 | Ticker: | XON | Exchange: | NASDAQ | Main Contact: | Donald P. Lehr, President | | Other Contacts: | Douglas E. Brough, Ph.D., CSO Jeffrey Perez, VP
| | Company Description | GenVec, an Intrexon commany, is a clinical-stage gene delivery company focused on developing a pipeline of cutting-edge therapeutics and vaccines using its proprietary AdenoVerse platform. The company is a pioneer in the design, testing and manufacture of adenoviral-based product candidates that can deliver on the promise of gene-based medicine. GenVec's lead product candidate, CGF166, is licensed to Novartis and is currently in a Phase 1/2 clinical study for the treatment of hearing loss and balance disorders. In addition to its internal and partnered pipeline, the company is also focused on opportunities to license its proprietary technology platform, including vectors and production cell lines, for the development and manufacture of therapeutics and vaccines to the biopharmaceutical industry. | |
|
|
|
|
|